The use of mesenchymal stem cell therapies in clinical practice without a solid scientific evidence base has the potential to risk patient safety and the credibility of the medical profession, says a leading rheumatologist. Professor David Hunter, Professor of Medicine at University of Sydney and the Royal North Shore Hospital and Consultant Rheumatologist at North ...
Warning over stem cell therapy for musculoskeletal diseases
By Amanda Sheppeard
10 Feb 2016